Los Angeles Capital Management Portfolio holdings
AUM
$26.7B
1-Year Return
35.08%
This Quarter Return
+10.54%
1 Year Return
+35.08%
3 Year Return
+164.18%
5 Year Return
+293.76%
10 Year Return
+832%
AUM
$22.7B
AUM Growth
+$567M
(+2.6%)
Cap. Flow
-$1.47B
Cap. Flow
% of AUM
-6.48%
Top 10 Holdings %
Top 10 Hldgs %
30.36%
Holding
1,757
New
185
Increased
417
Reduced
837
Closed
239
Top Buys
| 1 |
Everest Group
EG
|
+$96.9M |
| 2 |
United Parcel Service
UPS
|
+$86M |
| 3 |
Take-Two Interactive
TTWO
|
+$82.7M |
| 4 |
Zoom
ZM
|
+$70.4M |
| 5 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$68.2M |
Top Sells
| 1 |
Procter & Gamble
PG
|
+$165M |
| 2 |
HCA Healthcare
HCA
|
+$102M |
| 3 |
ResMed
RMD
|
+$82.4M |
| 4 |
Alibaba
BABA
|
+$82.1M |
| 5 |
Monster Beverage
MNST
|
+$74.7M |
Sector Composition
| 1 | Technology | 31.11% |
| 2 | Consumer Discretionary | 14.12% |
| 3 | Communication Services | 13.21% |
| 4 | Financials | 12.25% |
| 5 | Healthcare | 11.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1501
Alphatec Holdings
ATEC
$2.34B
| $158K | ﹤0.01% |
10,330
-2,842
| -22% | -$43.5K |
|
1502
Curis
CRIS
$22.6M
| $155K | ﹤0.01% |
+958
| New | +$155K |
|
1503
BGC Group
BGC
$4.76B
| $152K | ﹤0.01% |
26,772
| – | – |
|
|
OPTN
1504
DELISTED
OptiNose
OPTN
| $146K | ﹤0.01% |
3,138
-180
| -5% | -$8.38K |
|
1505
Fortress Biotech
FBIO
$107M
| $126K | ﹤0.01% |
2,353
-146
| -6% | -$7.82K |
|
1506
Clear Channel Outdoor Holdings
CCO
$666M
| $121K | ﹤0.01% |
+45,670
| New | +$121K |
|
1507
Abeona Therapeutics
ABEO
$350M
| $120K | ﹤0.01% |
3,087
-15,354
| -83% | -$597K |
|
1508
Stereotaxis
STXS
$263M
| $117K | ﹤0.01% |
12,150
-20
| -0.2% | -$193 |
|
1509
Minerva Neurosciences
NERV
$15M
| $116K | ﹤0.01% |
6,243
-17,149
| -73% | -$319K |
|
|
RRD
1510
DELISTED
RR Donnelley & Sons Co.
RRD
| $114K | ﹤0.01% |
+18,230
| New | +$114K |
|
1511
Ovid Therapeutics
OVID
$88.2M
| $111K | ﹤0.01% |
28,360
-4,500
| -14% | -$17.6K |
|
1512
MEI Pharma
MEIP
$91.3M
| $106K | ﹤0.01% |
1,860
-100
| -5% | -$5.7K |
|
|
SCPX
1513
DELISTED
Scorpius Holdings, Inc.
SCPX
| $96K | ﹤0.01% |
4
| – | – |
|
|
EGIO
1514
DELISTED
Edgio, Inc. Common Stock
EGIO
| $92K | ﹤0.01% |
732
-512
| -41% | -$64.4K |
|
1515
Alto Ingredients
ALTO
$89.8M
| $79K | ﹤0.01% |
+12,961
| New | +$79K |
|
1516
ADMA Biologics
ADMA
$3.91B
| $59K | ﹤0.01% |
37,165
-2,100
| -5% | -$3.33K |
|
1517
Cartesian Therapeutics
RNAC
$262M
| $45K | ﹤0.01% |
+359
| New | +$45K |
|
1518
Verastem
VSTM
$611M
| $45K | ﹤0.01% |
930
-5,470
| -85% | -$265K |
|
|
PMT
1519
PennyMac Mortgage Investment
PMT
$1.08B
| – | – |
-61,749
| Closed | -$1.21M |
|
1520
Pentair
PNR
$17.9B
| – | – |
-9,275
| Closed | -$578K |
|
1521
Purple Innovation
PRPL
$115M
| – | – |
-19,409
| Closed | -$614K |
|
1522
Pure Storage
PSTG
$25.9B
| – | – |
-9,340
| Closed | -$201K |
|
1523
PTC Therapeutics
PTCT
$4.64B
| – | – |
-5,332
| Closed | -$252K |
|
1524
Protagonist Therapeutics
PTGX
$3.63B
| – | – |
-47,387
| Closed | -$1.23M |
|
1525
Qualys
QLYS
$4.8B
| – | – |
-8,754
| Closed | -$917K |
|